Biocon Biologics and Regeneron Settle over Yesafili’s (Biosimilar, Eylea) US Launch
Shots: Biocon Biologics & Regeneron have entered into a settlement & licen...
Celltrion’s Yuflyma (Biosimilar, Humira) Receives the US FDA’s Interchangeability Designation
Shots: The US FDA has granted interchangeability designation to Yuflyma, a biosimi...
Intas Pharmaceuticals Acquires Coherus BioSciences’ Udenyca Business (Biosimilar, Neulasta)
Shots: Intas has acquired Coherus’ Udenyca business (incl. prefilled syringe...
The US FDA Approves Biocon Biologics’ Jobevne (Biosimilar, Avastin)
Shots: The US FDA has approved Jobevne, a biosimilar version of Avastin (bevacizum...
Teva and Samsung Bioepis Launch Epysqli (Biosimilar, Soliris) in the US
Shots: Teva & Samsung Bioepis have launched Epysqli, a biosimilar version of S...
Accord Healthcare Reports the CHMP’s Positive Opinion on Osvyrti and Jubereq (Biosimilar, Prolia & Xgeva)
Shots: The CHMP has recommended Osvyrti & Jubereq, biosimilar versions of Amge...
